bisbenzimidazole has been researched along with Cancer of Pituitary in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HS | 1 |
| Ishizaka, M | 1 |
| Kazusaka, A | 1 |
| Fujita, S | 1 |
1 other study available for bisbenzimidazole and Cancer of Pituitary
| Article | Year |
|---|---|
Di-(2-ethylhexyl) phthalate suppresses tamoxifen-induced apoptosis in GH3 pituitary cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Bisbenzimidazole; Blotting, Western; Cell Line, | 2007 |